Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors
Abstract Substance P (SP) is a widely distributed neuropeptide that works as a neurotransmitter and neuromodulator. Recently, SP receptors, particularly neurokinin-1 receptors (NK1 -Rs) that have a high affinity for SP, have been observed not only in neuron and immune cells, but also in other periph...
Gespeichert in:
Veröffentlicht in: | Neuropeptides (Edinburgh) 2007-02, Vol.41 (1), p.25-31 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 31 |
---|---|
container_issue | 1 |
container_start_page | 25 |
container_title | Neuropeptides (Edinburgh) |
container_volume | 41 |
creator | Goto, T Nakao, K Gunjigake, K.K Kido, M.A Kobayashi, S Tanaka, T |
description | Abstract Substance P (SP) is a widely distributed neuropeptide that works as a neurotransmitter and neuromodulator. Recently, SP receptors, particularly neurokinin-1 receptors (NK1 -Rs) that have a high affinity for SP, have been observed not only in neuron and immune cells, but also in other peripheral cells, including bone cells. To identify the role of SP in bone formation, we investigated the expression of NK1 -Rs in osteoblastic cells and the effects of SP on bone formation by rat calvarial osteoblastic cells. Rat calvarial osteoblastic cells were isolated and cultured for 3 weeks in alpha-MEM containing 10% serum, ascorbic acid, dexamethasone, and beta-glycerophosphate. We then investigated NK1 -R expression, SP effects on osteoblastic bone formation, and osteocalcin mRNA expression in osteoblastic cells. RT-PCR and immunocytochemistry showed that NK1 -R mRNA was expressed and NK1 -R was present in 14-day, but not 7-day, cultured calvarial osteoblasts. Bone formation by cultured osteoblastic cells significantly increased after the addition of 10−8 –10−6 M SP. During 3 weeks of culture, the addition of SP in the first week did not significantly increase bone formation, whereas adding SP during the first and second week or all 3 weeks significantly increased calvarial osteoblastic bone formation. Furthermore, semi-quantitative RT-PCR indicated that SP stimulated osteocalcin mRNA expression in the osteoblasts at day 14 or day 21, whereas SP did not stimulated the runX2 or type I collagen mRNA expression at day 7 but stimulated them at day 14. These results indicate that SP stimulates bone formation by osteoblastic cells via NK1 -Rs at late-stage bone formation. These effects were dependent on the expression of NK1 -R in osteoblastic cells. Our findings suggest that SP secreted from sensory neurons may modulate bone formation after the expression of SP receptors. |
doi_str_mv | 10.1016/j.npep.2006.11.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68424568</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0143417906001491</els_id><sourcerecordid>19594112</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-592d22789b2fb267701b0c5ffccff62c9f6e7b1fcd3c1ebababeb8b27263a5ba3</originalsourceid><addsrcrecordid>eNqFkl9r3iAUxmVsrO-6fYFdDG-2u2Qek5gExqCU_YNCC92unZpj69skZmoK_fYzvC8UdrEiqODvOR6e5xDyFlgJDMTHfTkvuJScMVEClIzxZ2QHTcUL3nbNc7JjUFdFDW1_Ql7FuGeM1bzrXpITaDmrK17tyO_rVcekZoP0isbkpnVUCSPd9iI_3CANKlEfE3o9qkwYqv2M1PowqeT8TNNt8OvNLZ1xDf7OzW4ugAY0uCQf4mvywqox4pvjeUp-ff3y8_x7cXH57cf52UVhmkqkoun5wHPbveZWc9G2DDQzjbXGWCu46a3AVoM1Q2UAtcoLdad5y0WlGq2qU_LhUHcJ_s-KMcnJRYPjqGb0a5Siq3ndiO5JEPqmrwF4BvkBNMHHGNDKJbhJhQcJTG4ByL3cApBbABJA5gCy6N2x-qonHB4lR8cz8P4IqGjUaEP23sVHrqsF8L7N3KcDh9m0e4dBRuMw5zS47G2Sg3f_7-PzP3Iz5mjyj3f4gHHv1zDnOCTIyCWT19uobJPCBMvXHqq_lxa7IQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19594112</pqid></control><display><type>article</type><title>Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Goto, T ; Nakao, K ; Gunjigake, K.K ; Kido, M.A ; Kobayashi, S ; Tanaka, T</creator><creatorcontrib>Goto, T ; Nakao, K ; Gunjigake, K.K ; Kido, M.A ; Kobayashi, S ; Tanaka, T</creatorcontrib><description>Abstract Substance P (SP) is a widely distributed neuropeptide that works as a neurotransmitter and neuromodulator. Recently, SP receptors, particularly neurokinin-1 receptors (NK1 -Rs) that have a high affinity for SP, have been observed not only in neuron and immune cells, but also in other peripheral cells, including bone cells. To identify the role of SP in bone formation, we investigated the expression of NK1 -Rs in osteoblastic cells and the effects of SP on bone formation by rat calvarial osteoblastic cells. Rat calvarial osteoblastic cells were isolated and cultured for 3 weeks in alpha-MEM containing 10% serum, ascorbic acid, dexamethasone, and beta-glycerophosphate. We then investigated NK1 -R expression, SP effects on osteoblastic bone formation, and osteocalcin mRNA expression in osteoblastic cells. RT-PCR and immunocytochemistry showed that NK1 -R mRNA was expressed and NK1 -R was present in 14-day, but not 7-day, cultured calvarial osteoblasts. Bone formation by cultured osteoblastic cells significantly increased after the addition of 10−8 –10−6 M SP. During 3 weeks of culture, the addition of SP in the first week did not significantly increase bone formation, whereas adding SP during the first and second week or all 3 weeks significantly increased calvarial osteoblastic bone formation. Furthermore, semi-quantitative RT-PCR indicated that SP stimulated osteocalcin mRNA expression in the osteoblasts at day 14 or day 21, whereas SP did not stimulated the runX2 or type I collagen mRNA expression at day 7 but stimulated them at day 14. These results indicate that SP stimulates bone formation by osteoblastic cells via NK1 -Rs at late-stage bone formation. These effects were dependent on the expression of NK1 -R in osteoblastic cells. Our findings suggest that SP secreted from sensory neurons may modulate bone formation after the expression of SP receptors.</description><identifier>ISSN: 0143-4179</identifier><identifier>EISSN: 1532-2785</identifier><identifier>DOI: 10.1016/j.npep.2006.11.002</identifier><identifier>PMID: 17204323</identifier><identifier>CODEN: NRPPDD</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Advanced Basic Science ; Animals ; Biological and medical sciences ; Bone Development - drug effects ; Bone Development - physiology ; Bone formation ; Cell Differentiation - drug effects ; Cell Differentiation - physiology ; Collagen - drug effects ; Dipeptides - pharmacology ; DNA Primers ; Endocrinology & Metabolism ; Fundamental and applied biological sciences. Psychology ; Indoles - pharmacology ; Neurokinin-1 receptor ; Osteoblastic cell ; Osteoblasts - drug effects ; Osteoblasts - physiology ; Rats ; Rats, Inbred Strains ; Receptors, Neurokinin-1 - drug effects ; Receptors, Neurokinin-1 - physiology ; RNA, Messenger - genetics ; Substance P ; Substance P - analogs & derivatives ; Substance P - pharmacology ; Vertebrates: endocrinology</subject><ispartof>Neuropeptides (Edinburgh), 2007-02, Vol.41 (1), p.25-31</ispartof><rights>Elsevier Ltd</rights><rights>2006 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-592d22789b2fb267701b0c5ffccff62c9f6e7b1fcd3c1ebababeb8b27263a5ba3</citedby><cites>FETCH-LOGICAL-c536t-592d22789b2fb267701b0c5ffccff62c9f6e7b1fcd3c1ebababeb8b27263a5ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.npep.2006.11.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18461297$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17204323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goto, T</creatorcontrib><creatorcontrib>Nakao, K</creatorcontrib><creatorcontrib>Gunjigake, K.K</creatorcontrib><creatorcontrib>Kido, M.A</creatorcontrib><creatorcontrib>Kobayashi, S</creatorcontrib><creatorcontrib>Tanaka, T</creatorcontrib><title>Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors</title><title>Neuropeptides (Edinburgh)</title><addtitle>Neuropeptides</addtitle><description>Abstract Substance P (SP) is a widely distributed neuropeptide that works as a neurotransmitter and neuromodulator. Recently, SP receptors, particularly neurokinin-1 receptors (NK1 -Rs) that have a high affinity for SP, have been observed not only in neuron and immune cells, but also in other peripheral cells, including bone cells. To identify the role of SP in bone formation, we investigated the expression of NK1 -Rs in osteoblastic cells and the effects of SP on bone formation by rat calvarial osteoblastic cells. Rat calvarial osteoblastic cells were isolated and cultured for 3 weeks in alpha-MEM containing 10% serum, ascorbic acid, dexamethasone, and beta-glycerophosphate. We then investigated NK1 -R expression, SP effects on osteoblastic bone formation, and osteocalcin mRNA expression in osteoblastic cells. RT-PCR and immunocytochemistry showed that NK1 -R mRNA was expressed and NK1 -R was present in 14-day, but not 7-day, cultured calvarial osteoblasts. Bone formation by cultured osteoblastic cells significantly increased after the addition of 10−8 –10−6 M SP. During 3 weeks of culture, the addition of SP in the first week did not significantly increase bone formation, whereas adding SP during the first and second week or all 3 weeks significantly increased calvarial osteoblastic bone formation. Furthermore, semi-quantitative RT-PCR indicated that SP stimulated osteocalcin mRNA expression in the osteoblasts at day 14 or day 21, whereas SP did not stimulated the runX2 or type I collagen mRNA expression at day 7 but stimulated them at day 14. These results indicate that SP stimulates bone formation by osteoblastic cells via NK1 -Rs at late-stage bone formation. These effects were dependent on the expression of NK1 -R in osteoblastic cells. Our findings suggest that SP secreted from sensory neurons may modulate bone formation after the expression of SP receptors.</description><subject>Advanced Basic Science</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bone Development - drug effects</subject><subject>Bone Development - physiology</subject><subject>Bone formation</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Differentiation - physiology</subject><subject>Collagen - drug effects</subject><subject>Dipeptides - pharmacology</subject><subject>DNA Primers</subject><subject>Endocrinology & Metabolism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Indoles - pharmacology</subject><subject>Neurokinin-1 receptor</subject><subject>Osteoblastic cell</subject><subject>Osteoblasts - drug effects</subject><subject>Osteoblasts - physiology</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Receptors, Neurokinin-1 - drug effects</subject><subject>Receptors, Neurokinin-1 - physiology</subject><subject>RNA, Messenger - genetics</subject><subject>Substance P</subject><subject>Substance P - analogs & derivatives</subject><subject>Substance P - pharmacology</subject><subject>Vertebrates: endocrinology</subject><issn>0143-4179</issn><issn>1532-2785</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkl9r3iAUxmVsrO-6fYFdDG-2u2Qek5gExqCU_YNCC92unZpj69skZmoK_fYzvC8UdrEiqODvOR6e5xDyFlgJDMTHfTkvuJScMVEClIzxZ2QHTcUL3nbNc7JjUFdFDW1_Ql7FuGeM1bzrXpITaDmrK17tyO_rVcekZoP0isbkpnVUCSPd9iI_3CANKlEfE3o9qkwYqv2M1PowqeT8TNNt8OvNLZ1xDf7OzW4ugAY0uCQf4mvywqox4pvjeUp-ff3y8_x7cXH57cf52UVhmkqkoun5wHPbveZWc9G2DDQzjbXGWCu46a3AVoM1Q2UAtcoLdad5y0WlGq2qU_LhUHcJ_s-KMcnJRYPjqGb0a5Siq3ndiO5JEPqmrwF4BvkBNMHHGNDKJbhJhQcJTG4ByL3cApBbABJA5gCy6N2x-qonHB4lR8cz8P4IqGjUaEP23sVHrqsF8L7N3KcDh9m0e4dBRuMw5zS47G2Sg3f_7-PzP3Iz5mjyj3f4gHHv1zDnOCTIyCWT19uobJPCBMvXHqq_lxa7IQ</recordid><startdate>20070201</startdate><enddate>20070201</enddate><creator>Goto, T</creator><creator>Nakao, K</creator><creator>Gunjigake, K.K</creator><creator>Kido, M.A</creator><creator>Kobayashi, S</creator><creator>Tanaka, T</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20070201</creationdate><title>Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors</title><author>Goto, T ; Nakao, K ; Gunjigake, K.K ; Kido, M.A ; Kobayashi, S ; Tanaka, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-592d22789b2fb267701b0c5ffccff62c9f6e7b1fcd3c1ebababeb8b27263a5ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Advanced Basic Science</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bone Development - drug effects</topic><topic>Bone Development - physiology</topic><topic>Bone formation</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Differentiation - physiology</topic><topic>Collagen - drug effects</topic><topic>Dipeptides - pharmacology</topic><topic>DNA Primers</topic><topic>Endocrinology & Metabolism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Indoles - pharmacology</topic><topic>Neurokinin-1 receptor</topic><topic>Osteoblastic cell</topic><topic>Osteoblasts - drug effects</topic><topic>Osteoblasts - physiology</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Receptors, Neurokinin-1 - drug effects</topic><topic>Receptors, Neurokinin-1 - physiology</topic><topic>RNA, Messenger - genetics</topic><topic>Substance P</topic><topic>Substance P - analogs & derivatives</topic><topic>Substance P - pharmacology</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goto, T</creatorcontrib><creatorcontrib>Nakao, K</creatorcontrib><creatorcontrib>Gunjigake, K.K</creatorcontrib><creatorcontrib>Kido, M.A</creatorcontrib><creatorcontrib>Kobayashi, S</creatorcontrib><creatorcontrib>Tanaka, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropeptides (Edinburgh)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goto, T</au><au>Nakao, K</au><au>Gunjigake, K.K</au><au>Kido, M.A</au><au>Kobayashi, S</au><au>Tanaka, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors</atitle><jtitle>Neuropeptides (Edinburgh)</jtitle><addtitle>Neuropeptides</addtitle><date>2007-02-01</date><risdate>2007</risdate><volume>41</volume><issue>1</issue><spage>25</spage><epage>31</epage><pages>25-31</pages><issn>0143-4179</issn><eissn>1532-2785</eissn><coden>NRPPDD</coden><abstract>Abstract Substance P (SP) is a widely distributed neuropeptide that works as a neurotransmitter and neuromodulator. Recently, SP receptors, particularly neurokinin-1 receptors (NK1 -Rs) that have a high affinity for SP, have been observed not only in neuron and immune cells, but also in other peripheral cells, including bone cells. To identify the role of SP in bone formation, we investigated the expression of NK1 -Rs in osteoblastic cells and the effects of SP on bone formation by rat calvarial osteoblastic cells. Rat calvarial osteoblastic cells were isolated and cultured for 3 weeks in alpha-MEM containing 10% serum, ascorbic acid, dexamethasone, and beta-glycerophosphate. We then investigated NK1 -R expression, SP effects on osteoblastic bone formation, and osteocalcin mRNA expression in osteoblastic cells. RT-PCR and immunocytochemistry showed that NK1 -R mRNA was expressed and NK1 -R was present in 14-day, but not 7-day, cultured calvarial osteoblasts. Bone formation by cultured osteoblastic cells significantly increased after the addition of 10−8 –10−6 M SP. During 3 weeks of culture, the addition of SP in the first week did not significantly increase bone formation, whereas adding SP during the first and second week or all 3 weeks significantly increased calvarial osteoblastic bone formation. Furthermore, semi-quantitative RT-PCR indicated that SP stimulated osteocalcin mRNA expression in the osteoblasts at day 14 or day 21, whereas SP did not stimulated the runX2 or type I collagen mRNA expression at day 7 but stimulated them at day 14. These results indicate that SP stimulates bone formation by osteoblastic cells via NK1 -Rs at late-stage bone formation. These effects were dependent on the expression of NK1 -R in osteoblastic cells. Our findings suggest that SP secreted from sensory neurons may modulate bone formation after the expression of SP receptors.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17204323</pmid><doi>10.1016/j.npep.2006.11.002</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0143-4179 |
ispartof | Neuropeptides (Edinburgh), 2007-02, Vol.41 (1), p.25-31 |
issn | 0143-4179 1532-2785 |
language | eng |
recordid | cdi_proquest_miscellaneous_68424568 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Advanced Basic Science Animals Biological and medical sciences Bone Development - drug effects Bone Development - physiology Bone formation Cell Differentiation - drug effects Cell Differentiation - physiology Collagen - drug effects Dipeptides - pharmacology DNA Primers Endocrinology & Metabolism Fundamental and applied biological sciences. Psychology Indoles - pharmacology Neurokinin-1 receptor Osteoblastic cell Osteoblasts - drug effects Osteoblasts - physiology Rats Rats, Inbred Strains Receptors, Neurokinin-1 - drug effects Receptors, Neurokinin-1 - physiology RNA, Messenger - genetics Substance P Substance P - analogs & derivatives Substance P - pharmacology Vertebrates: endocrinology |
title | Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T21%3A08%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Substance%20P%20stimulates%20late-stage%20rat%20osteoblastic%20bone%20formation%20through%20neurokinin-1%20receptors&rft.jtitle=Neuropeptides%20(Edinburgh)&rft.au=Goto,%20T&rft.date=2007-02-01&rft.volume=41&rft.issue=1&rft.spage=25&rft.epage=31&rft.pages=25-31&rft.issn=0143-4179&rft.eissn=1532-2785&rft.coden=NRPPDD&rft_id=info:doi/10.1016/j.npep.2006.11.002&rft_dat=%3Cproquest_cross%3E19594112%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19594112&rft_id=info:pmid/17204323&rft_els_id=1_s2_0_S0143417906001491&rfr_iscdi=true |